By vgreene, 6 November, 2014 If FEV1 ≥50% predicted1 w/ 0-1 exacerbation/yr2 (none requiring hospitalization): Category A = few sx, low exacerbation risk
By vgreene, 6 November, 2014 General population screening is controversial. GOLD advocates active case-finding, not screening spirometry
By vgreene, 6 November, 2014 No data show that identifying pts before significant sx develop improves COPD outcomes or effectively directs management
By vgreene, 6 November, 2014 Imaging: CXR not useful for COPD dx; may exclude alternative dx or establish resp/CV comorbidities. CT not routine; may help DDx if COPD in doubt
By vgreene, 6 November, 2014 Assess risks. Exposures: smoke from tobacco/home cooking/heating fuel. Occupational dust/chemicals. FHx COPD.